 MINNEAPOLIS, MN ACCESSWIRE November 3, 2022 Celcuity Inc. NASDAQ:CELC, a clinical-stage biotechnology company focused on development of targeted therapies for a number of different cancers, today announced that it will release its financial results for the third quarter 2022 after the stock market close on Thursday, November 10, 2022. Management will host a webcastteleconference the same day at 4:30 p.m. 